Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases

2016 ◽  
pp. 117-123 ◽  
Author(s):  
Lucilla Parnetti ◽  
Paolo Eusebi ◽  
Alberto Lleó
Keyword(s):  
Clinical Trials ◽  
Cerebrospinal Fluid ◽  
Target Engagement ◽  
Cerebrospinal Fluid Biomarkers ◽  
Parkinson’S Diseases

Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer’s and Parkinson’s Diseases in Young Mexico City Residents

2016 ◽  
Vol 54 (2) ◽  
pp. 597-613 ◽  
Author(s):  
Lilian Calderón-Garcidueñas ◽  
José Avila-Ramírez ◽  
Ana Calderón-Garcidueñas ◽  
Tonatiuh González-Heredia ◽  
Hilda Acuña-Ayala ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Mexico City ◽  
Cerebrospinal Fluid Biomarkers ◽  
Parkinson’S Diseases

Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice

2016 ◽  
Vol 31 (6) ◽  
pp. 836-847 ◽  
Author(s):  
Kaj Blennow ◽  
Leonardo Biscetti ◽  
Paolo Eusebi ◽  
Lucilla Parnetti
Keyword(s):  
Cerebrospinal Fluid ◽  
Clinical Practice ◽  
Cerebrospinal Fluid Biomarkers ◽  
Parkinson’S Diseases

Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depression

2012 ◽  
Vol 6 (1) ◽  
pp. 119-129 ◽  
Author(s):  
Hong I Wan ◽  
Holly Soares ◽  
Jeffrey F Waring
Keyword(s):  
Clinical Trials ◽  
Cerebrospinal Fluid ◽  
Cerebrospinal Fluid Biomarkers
Sign in / Sign up

Export Citation Format

Share Document